Jessica Oien serves as Executive at Cidara Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jessica Oien has executed 8 insider transactions totaling $9.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 23, 2026 involved receiving (via award) 220,000 shares valued at $0.
Jessica Oien currently holds 220,000 shares of Cidara Therapeutics, Inc. (CDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jessica Oien has been a net seller of CDTX stock. They have purchased $0 and sold $9.9K worth of shares.
Jessica Oien's most recent insider trade was on Jan 23, 2026, when they sold 220,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.66 |
| Discretionary |
| Mar 31, 2021 | CDTX | $0 | Award | 2,800 | $N/A | Discretionary |
| Jan 5, 2021 | CDTX | $1.7K | Sale | 824 | $2.06 | Discretionary |
| Jan 2, 2020 | CDTX | $3.2K | Sale | 834 | $3.86 | Discretionary |
| Sep 27, 2019 | CDTX | $1.9K | Sale | 1,001 | $1.86 | Discretionary |
| Sep 12, 2019 | CDTX | $0 | Award | 2,800 | $N/A | Discretionary |
| Jan 31, 2019 | CDTX | $0 | Award | 6,000 | $N/A | Discretionary |